Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on ... - GlobeNewswire (press release)

UTC
US NEWS FEEDS > MASSACHUSETTS > WATERTOWN >

WATERTOWN , Mass ., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune responses, today ...and more »
...
News Feed:
Watertown Massachusetts - Google News

READ MORE >
Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on ... - GlobeNewswire (press release)

Sponsored Content